Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Solid and Hematological Malignancies”

423 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 423 results

Not applicableNot Yet RecruitingNCT07691008
What this trial is testing

Wearable Data for Personalized Prognostication in Cancer: A Registry Protocol

Who this might be right for
Hematopoietic NeoplasmMalignant Solid NeoplasmLymphatic System Neoplasm+1 more
City of Hope Medical Center 1,200
Testing effectiveness (Phase 2)UnknownNCT04082910
What this trial is testing

Metoprolol Treatment for Cytokine Release Syndrome in Patients Treated With Chimeric Antigen Receptor T Cells

Who this might be right for
Solid TumorHematological Malignancy
Chinese PLA General Hospital 30
Testing effectiveness (Phase 2)Active Not RecruitingNCT04439110
What this trial is testing

Testing Ado-Trastuzumab Emtansine as a Potential Targeted Treatment in Cancers With HER2 Genetic Changes (MATCH-Subprotocol Q)

Who this might be right for
Advanced LymphomaAdvanced Malignant Solid NeoplasmHematopoietic and Lymphoid Cell Neoplasm+3 more
National Cancer Institute (NCI) 38
Early research (Phase 1)Study completedNCT04257617
What this trial is testing

A Trial of ZL-1201 in Subjects With Advanced Cancer

Who this might be right for
Advanced Cancer
Zai Lab (Shanghai) Co., Ltd. 37
Early research (Phase 1)Study completedNCT01222780
What this trial is testing

To Evaluate the Safety, Activity and Pharmacokinetics of Marqibo in Children and Adolescents With Refractory Cancer

Who this might be right for
SarcomaNeuroblastomaWilms Tumor+3 more
Acrotech Biopharma Inc. 22
Early research (Phase 1)Ended earlyNCT05338346
What this trial is testing

ATG-018 (ATR Inhibitor) Treatment in Patients With Advanced Solid Tumors and Hematological Malignancies

Who this might be right for
Advanced Solid TumorsHematological Malignancies
Antengene Discovery Limited 22
Testing effectiveness (Phase 2)Ended earlyNCT04379518
What this trial is testing

Rintatolimod and IFN Alpha-2b for the Treatment of COVID-19 in Cancer Patients

Who this might be right for
Hematopoietic and Lymphoid Cell NeoplasmMalignant Solid NeoplasmSymptomatic COVID-19 Infection Laboratory-Confirmed
Roswell Park Cancer Institute 4
Not applicableStudy completedNCT05042479
What this trial is testing

Using of Virtual Reality to Relieve Procedural Pain in Pediatric Oncology.

Who this might be right for
Hematologic MalignancyHematologic Non MalignancySolid Tumor, Childhood+1 more
Nantes University Hospital 34
Not applicableNot Yet RecruitingNCT07825714
What this trial is testing

Metagenomic Sequencing Across the Infectious Disease Risk and Care Continuum

Who this might be right for
Infectious DiseasesImmunocompromised HostOpportunistic Infections
Karius, Inc. 10,000
Not applicableLooking for participantsNCT03016806
What this trial is testing

Umbilical Cord Blood Transplantation From Unrelated Donors

Who this might be right for
Acute LeukemiaImmune Deficiency DisorderCongenital Hematological Disorder+7 more
University of Rochester 30
Early research (Phase 1)Study completedNCT00004065
What this trial is testing

Chemotherapy in Treating Patients With Refractory Advanced Solid Tumors or Hematologic Cancer

Who this might be right for
Bladder CancerBreast CancerColorectal Cancer+9 more
Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Ended earlyNCT04347226
What this trial is testing

Anti-Interleukin-8 (Anti-IL-8) for Patients With COVID-19

Who this might be right for
Solid TumorSars-CoV2Hematological Malignancy
Columbia University 43
Early research (Phase 1)Study completedNCT02680795
What this trial is testing

Establish the PK of Belinostat in Patients With Wild-type, Heterozygous, and Homozygous UGT1A1*28 Genotypes

Who this might be right for
Solid TumorsHematological Malignancies
Acrotech Biopharma Inc. 17
Early research (Phase 1)Study completedNCT01949545
What this trial is testing

Study of the Pharmacokinetics and Safety of Carfilzomib in Patients With Advanced Malignancies and Hepatic Impairment

Who this might be right for
Solid TumorsHematologic MalignanciesHepatic Impairment
Amgen 46
Testing effectiveness (Phase 2)Active Not RecruitingNCT04439123
What this trial is testing

Testing AZD5363 as a Potential Targeted Treatment in Cancers With AKT Genetic Changes (MATCH-Subprotocol Y)

Who this might be right for
Advanced LymphomaAdvanced Malignant Solid NeoplasmHematopoietic and Lymphoid Cell Neoplasm+3 more
National Cancer Institute (NCI) 35
Testing effectiveness (Phase 2)Study completedNCT04847050
What this trial is testing

A Trial of the Safety and Immunogenicity of the COVID-19 Vaccine (mRNA-1273) in Participants With Hematologic Malignancies and Various Regimens of Immunosuppression, and in Participants With Solid Tumors on PD1/PDL1 Inhibitor Therapy

Who this might be right for
Solid Tumor MalignancyHematologic MalignancyLeukemia+2 more
National Cancer Institute (NCI) 19
Early research (Phase 1)Study completedNCT01375842
What this trial is testing

Atezolizumab (an Engineered Anti-Programmed Death-Ligand 1 [PDL1] Antibody) to Evaluate Safety, Tolerability and Pharmacokinetics in Participants With Locally Advanced or Metastatic Solid Tumors

Who this might be right for
TumorsHematologic Malignancies
Genentech, Inc. 661
Not applicableActive Not RecruitingNCT04888988
What this trial is testing

Testing the Effects of Exercise on Chemotherapy-Induced Peripheral Neuropathy

Who this might be right for
Chemotherapy-Induced Peripheral NeuropathyHematopoietic and Lymphoid Cell NeoplasmMalignant Solid Neoplasm
University of Rochester NCORP Research Base 133
Testing effectiveness (Phase 2)Study completedNCT04552288
What this trial is testing

Study of Benralizumab in People With Skin Side Effects Caused by Cancer Therapies

Who this might be right for
Solid TumorSolid CarcinomaSolid Tumor, Adult+1 more
Memorial Sloan Kettering Cancer Center 51
Testing effectiveness (Phase 2)Ended earlyNCT03648372
What this trial is testing

TAK-981 in People With Advanced Solid Tumors or Cancers in the Immune System

Who this might be right for
NeoplasmsLymphomaHematologic Neoplasms
Takeda 109
Next Page